A pH fluorescence sensor compound and its preparation and application

By designing and synthesizing new pH fluorescent sensor compounds, the scarcity and complex synthesis of neutral to alkaline pH-responsive fluorescent sensors are solved, and high sensitivity detection and biological application of pH changes are achieved, with simplicity, stability and anti-interference Features.

CN116478106BInactive Publication Date: 2024-11-22SHANXI DATONG UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202310440960.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-23
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, there are few fluorescent sensors with neutral to alkaline pH response and cumbersome synthesis, making it difficult to achieve simple and effective pH detection.

Method used

Design and synthesize a new pH fluorescent sensor compound (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazole-5-yl)vinyl)phenol, by Specific synthesis methods and application methods to achieve high sensitivity detection of pH changes.

Benefits of technology

This compound is highly sensitive to pH changes, is easy to synthesis, is good in water solubility, can be used in biological analysis, cell imaging and drug delivery, has good anti-interference ability and stability, and can achieve a neutral to alkaline pH range to real-time monitoring within.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116478106B_ABST
    Figure CN116478106B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of detecting pH fluorescence sensors, and in particular to a compound for detecting pH fluorescence sensors and its preparation and application. 4-(diethylamino) salicylaldehyde, 3,5-dimethyl-4-nitroisoxazole and piperidine are dissolved in anhydrous ethanol for reflux, evaporated under reduced pressure to remove the solvent, dissolved in dichloromethane and purified by column chromatography to obtain a pink solid, which is the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazole-5-yl)vinyl)phenol compound. Compared with the existing pH fluorescence sensors, the fluorescence sensor of the present invention has a very high sensitivity in response to alkaline systems, is not interfered by backgrounds such as common active substances, has good water solubility, and has excellent performance in terms of cytotoxicity. In view of this, it can be used as a pH sensor in biological analysis, cell imaging, targeted organelles, and drug delivery and release with good application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pH detection fluorescent sensors, and in particular to a pH detection fluorescent sensor compound and preparation and application thereof. Background Art

[0002] As a key physiological indicator of cells, pH is related to many physiological processes. The appropriate pH balance in cells plays a vital role in regulating and maintaining a variety of biological processes such as cell proliferation, membrane transport, enzyme activity and protein synthesis. Unbalanced pH fluctuations in cells may be related to cell dysfunction, which can easily induce mutations in cell function, growth and division, and may cause various neurodegenerative diseases such as cancer, Alzheimer's disease and Parkinson's disease. The detection of intracellular pH can provide us with important information for studying intracellular physiological and pathological processes.

[0003] pH is not only an important physiological indicator of the human body, but also plays an extremely important role in human daily life. pH is one of the most important physical and chemical parameters of aqueous solutions. All natural phenomena, chemical changes and production processes involving aqueous solutions are related to pH. Therefore, pH measurement is required in industry, agriculture, medicine, environmental protection and scientific research. There are many ways to detect pH, such as acid-base titration, potentiometric titration, etc. However, these methods are expensive, inconvenient to operate and easily interfered by other ions. The fluorescent probe method is increasingly popular with its unique advantages such as high sensitivity, good selectivity, fast response time, specific response to pH and no damage to cells.

[0004] Currently, there are relatively few fluorescent sensors that respond to neutral to alkaline pH, and their synthesis is cumbersome. Therefore, it is particularly valuable to develop new fluorescent sensors that can detect simple and novel neutral to alkaline pH. To address this problem, we designed and synthesized a new pH sensor, REDS, which is highly sensitive to pH changes. Compared with existing pH-sensitive fluorescent sensors, REDS has the advantages of simple synthesis, good water solubility, and strong cell imaging ability. Summary of the invention

[0005] In order to solve the problems that neutral to alkaline pH responsive fluorescent sensors are relatively rare and their synthesis is complicated, the present invention provides a fluorescent sensor compound for detecting pH and its preparation and application.

[0006] The present invention is achieved by the following technical scheme: (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound, the structural formula of which is shown below:

[0007]

[0008] The present invention further provides a method for preparing a (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazole-5-yl)vinyl)phenol compound. 4-(diethylamino)salicylaldehyde, 3,5-dimethyl-4-nitroisoxazole and piperidine are dissolved in anhydrous ethanol and refluxed. After the solvent is removed by evaporation under reduced pressure, the solid is dissolved in dichloromethane and purified by column chromatography to obtain a pink solid, which is the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazole-5-yl)vinyl)phenol compound.

[0009] As a further improvement of the technical solution of the preparation method of the present invention, the molar ratio of 4-(diethylamino) salicylaldehyde to 3,5-dimethyl-4-nitroisoxazole is 2:1.

[0010] As a further improvement of the technical solution of the preparation method of the present invention, the molar ratio of 4-(diethylamino) salicylaldehyde, 3,5-dimethyl-4-nitroisoxazole and piperidine is 7:3.5:3.

[0011] As a further improvement of the technical solution of the preparation method of the present invention, the reflux time is 72 hours.

[0012] As a further improvement of the technical solution of the preparation method of the present invention, the column chromatography purification system is petroleum ether and ethyl acetate in a volume ratio of 6:1.

[0013] The present invention further provides the use of the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound in detecting pH.

[0014] As a further improvement of the above application technical solution, the compound detects pH through ultraviolet-visible absorption spectrum or fluorescence intensity change.

[0015] The present invention also provides the use of (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound as a pH sensor in biological analysis, cell imaging, targeting organelles, drug delivery and release.

[0016] The compound described in the present invention has good spectral response performance to pH. First, the ultraviolet-visible absorption spectrum is studied. When the pH increases from 3 to 12, the maximum absorption wavelength red-shifts from 522nm to 580nm, and the absorption intensity increases. Secondly, the fluorescence spectrum performance is studied. The fluorescence sensor emits strong fluorescence at 578nm in an acidic or neutral medium. As the alkalinity gradually increases, the fluorescence intensity at 578nm gradually decreases, and a new fluorescence peak appears at 616nm. And when the pH increases from 3 to 12, the fluorescence intensity at 578nm decreases by about 74.41 times. In the range of pH=7.5-9.5, the fluorescence intensity at 578nm has a good linear relationship with the pH value. Real-time monitoring of changes in pH value in a solution system is achieved.

[0017] The compounds of the present invention have very good anti-interference ability to pH. At pH = 4.0 and pH = 11.0, the fluorescence sensor is + , K + , Al 3+ , Ba 2+ , Ca 2+ , Cu 2+ , Fe 3+ ,Mg 2+ , Sn 2+ , Zn 2+ In the system where glutathione (GSH) exists, the change of fluorescence intensity is measured, and it is found that only pH can cause the change of fluorescence intensity, and it is not affected by common active substances.

[0018] Compared with the existing pH fluorescence sensors, the fluorescence sensor of the present invention has a very high sensitivity in response to alkaline systems, is not interfered by the background of common active substances, has good water solubility, and has excellent performance in cytotoxicity, etc. Therefore, it can be used as a pH sensor in biological analysis, cell imaging, targeting organelles, and drug delivery and release, and has good application prospects.

[0019] The fluorescence sensor of the present invention has the following significant features:

[0020] (1) Under alkaline conditions (7.5-9.5), the solution color changes from pink to blue, which can be identified by naked eyes;

[0021] (2) Strong anti-interference ability, sensitive to pH, and not affected by other common active substances;

[0022] (3) The pH detection has excellent stability and reversibility;

[0023] (4) Fluorescence microscopy imaging of pH changes in living cells can be achieved. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.

[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0026] Figure 1 It is the hydrogen nuclear magnetic resonance spectrum of compound 1 of the present invention in deuterated DMSO.

[0027] Figure 2 It is the carbon nuclear magnetic resonance spectrum of compound 1 of the present invention in deuterated DMSO.

[0028] Figure 3 is the mass spectrum of compound 1 of the present invention.

[0029] Figure 4 The figure is the UV / visible absorption spectrum of the sensor REDS (5 μmol / L) of the present invention in different pH systems. The horizontal axis is the wavelength (nm) and the vertical axis is the absorbance. The arrows indicate that the pH changes from small to large are 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12.

[0030] Figure 5 It is the fluorescence spectra of the sensor REDS (5 μmol / L) of the present invention in different pH systems. The horizontal axis is the wavelength (nm) and the vertical axis is the fluorescence intensity. Excitation wavelength: 522nm. The arrows indicate that the pH changes from small to large are 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12.

[0031] Figure 6 The graph is a relationship between the fluorescence intensity of the sensor REDS (5 μmol / L) of the present invention at 578 nm and the pH value. The horizontal axis is pH, and the vertical axis is the fluorescence intensity. The excitation wavelength is 522 nm.

[0032] Figure 7 This is a linear relationship diagram of the fluorescence intensity of the sensor REDS (5 μmol / L) of the present invention at 578 nm and pH between 7.5 and 9.5. The horizontal axis is pH, and the vertical axis is fluorescence intensity. Excitation wavelength: 522 nm.

[0033] Figure 8The fluorescence spectrum of the sensor REDS (5 μmol / L) of the present invention after adding different metal cations and GSH in a system of pH = 4.0. The horizontal axis is the wavelength (nm), and the vertical axis is the fluorescence intensity. Excitation wavelength: 522 nm.

[0034] Fig. 9 The fluorescence spectrum of the sensor REDS (5 μmol / L) of the present invention after adding different metal cations and GSH in a system of pH=11.0. The horizontal axis is the wavelength (nm), and the vertical axis is the fluorescence intensity. Excitation wavelength: 522 nm.

[0035] Fig.10 This is a graph showing the relationship between the fluorescence intensity of the sensor REDS (5 μmol / L) of the present invention at 578 nm and time. The horizontal axis is time (min), and the vertical axis is fluorescence intensity. Excitation wavelength: 522 nm.

[0036] Fig.11 It is a line graph showing the change in the fluorescence intensity ratio at 578 nm when the sensor REDS (5 μmol / L) of the present invention is switched back and forth between pH 4.0 and 11.0 for 8 times. Excitation wavelength: 522 nm.

[0037] Fig.12 This is a diagram of cytotoxicity analysis of the sensor REDS (5 μmol / L) of the present invention. The abscissa is the concentration (μg / ml), and the ordinate is the survival rate (%).

[0038] Fig.13 The confocal fluorescence images of the sensor REDS (5 μmol / L) of the present invention incubated with HepG2 cells in PBS buffer solutions with pH values ​​of 7.5, 8, 8.5, and 9. (a) Fluorescence image, red channel: λem=560-600nm (λex=540nm); (b) cell bright field; (c) superposition of the fluorescence image and the respective bright field images. DETAILED DESCRIPTION

[0039] In order to more clearly understand the above-mentioned objectives, features and advantages of the present invention, the scheme of the present invention will be further described below. It should be noted that the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

[0040] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein; it is obvious that the embodiments in the specification are only part of the embodiments of the present invention, rather than all of the embodiments.

[0041] The various reagents and raw materials used in the present invention are all commercially available, or can be simply prepared from raw materials known in the art by methods known to those skilled in the art or methods disclosed in the prior art.

[0042] In order to make the present invention more fully understood by those skilled in the art, the present invention will be described in detail below in conjunction with the accompanying drawings and embodiments. These embodiments are merely illustrative and do not limit the present invention in any way.

[0043] Example 1: Preparation of (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol (Compound 1)

[0044] 4-(Diethylamino) salicylaldehyde (0.97 g, 7 mmol) and 3,5-dimethyl-4-nitroisoxazole (0.50 g, 3.52 mmol) and 3 mmol piperidine were dissolved in 100 mL of anhydrous ethanol and refluxed for 72 h. After the solvent was removed by evaporation under reduced pressure, it was dissolved in a small amount of dichloromethane and purified by column chromatography in a system of petroleum ether: ethyl acetate = 6:1 to obtain a pink solid product, which is compound 1.

[0045] The present invention also provides a specific reaction route of the above preparation method:

[0046]

[0047] H NMR spectrum of compound 1: 1 H NMR (500MHz, DMSO-d6) δ10.37(s,1H),7.89(d,J=16.2Hz,1H),7.49(d,J=16.2Hz,1H),7.44(d,J=9.0Hz,1H), 6.35–6.29(m,1H),6.18(d,J=2.2Hz,1H),3.38(dd,J=13.8,6.8Hz,4H),2.46(s,3H),1.13(t,J=6.8Hz,6H); see attachment Figure 1 .

[0048] Carbon NMR spectrum determination of compound 1: 13 C NMR (125 MHz, DMSO-d6) δ 168.91, 160.60, 156.27, 152.10, 140.85, 132.64, 125.49, 110.40, 105.31, 103.56, 97.56, 44.56, 13.07, 12.18; MALDI-TOF theoretical value: C 16 H 19 N3O4[M]317.1376, measured value: 317.1371. See attached Figure 2.

[0049] The theoretical value of high resolution mass spectrometry (HRMS) of compound 1 is C 16 H 19 N3O4[M]317.1376; experimentally measured: 317.1371. See attached Figure 3 .

[0050] Example 2: UV-Visible absorption spectra of compound 1 of the present invention at different pH values

[0051] (1) Preparation of stock solution

[0052] Compound 1 was dissolved in N,N-dimethylformamide (DMF) to prepare the sensor REDS (5.0 mM) as a mother solution.

[0053] The sensors REDS used in the following examples of the present invention are all obtained by diluting the above mother liquor with N,N-dimethylformamide (DMF).

[0054] (2) Adjusting pH

[0055] The pH value was adjusted by adding HCl and NaOH solutions.

[0056] (3) UV-visible absorption spectrum measurement

[0057] In the sensor REDS with a concentration of 5μmol / L, the pH values ​​were adjusted to 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12, and the UV-visible absorption spectrum of the system was measured. The results showed that at pH = 3.0, the maximum absorption wavelength of the sensor REDS was about 522nm. As the pH increased from 3 to 12, the maximum absorption wavelength of the sensor REDS red-shifted, and the maximum absorption peak red-shifted from 522nm to 580nm, and the absorption intensity increased. See attached Figure 4 .

[0058] Example 3: Fluorescence spectroscopy of compound 1 of the present invention at different pH values

[0059] In the sensor REDS with a concentration of 5μmol / L, the pH values ​​were adjusted to 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, and the fluorescence spectrum of the system was measured at an excitation wavelength of 522nm using a HITACHI F2500 fluorescence spectrophotometer. The results showed that the sensor REDS emitted strong fluorescence in an acidic or neutral medium (pH = 3.0 ~ 7.0). As the alkalinity of the solution gradually increased, the fluorescence intensity of the sensor REDS at 578nm gradually decreased, and a new fluorescence peak appeared at 616nm. This may be because there is a hydrogen bond between the hydroxyl group and the oxygen atom in the nitro group in the probe. In an alkaline environment, the probe undergoes a deprotonation process, the hydrogen bond is destroyed, the intramolecular electron transfer is enhanced, and the fluorescence emission peak is red-shifted. See attached Figure 5 .

[0060] When the pH value increases from 3 to 12, the fluorescence intensity of the sensor REDS at 578nm decreases by about 74.41 times. The pKa of the sensor REDS is 7.96 obtained by Sigmoidal curve fitting using the Hendersone-Hasselbach equation. Figure 6 .

[0061] In the range of pH = 7.5 to 9.5, there is a good linear relationship between the fluorescence intensity at 578nm and the pH value. Figure 7 .

[0062] Example 4: Determination of the anti-interference ability of compound 1 of the present invention as a fluorescence sensor

[0063] The sensor REDS (5 μM) was investigated for different concentrations of interfering substances (Na + :10mM, K + :10mM,Al 3+ :100μM, Ba 2+ :100μM, Ca 2+ :500μM,Cu 2+ :100μM,Fe 3+ :100μM, Mg 2+ :500μM, Sn 2+ :100μM, Zn 2+:500μM, glutathione (GSH):5.0mM). The synthesized compound 1 was prepared into a 5mM mother solution with N,N-dimethylformamide, and after diluting it to 5μmol / L, the pH value was adjusted to 4 and 11 by adding HCl and NaOH solutions. After adjustment, 3mL of PBS buffer solution and 3μL of various test substance solutions of different concentrations were added respectively, mixed evenly and added to the cuvette. The excitation wavelength was selected as 522nm, and the fluorescence spectrum of the measurement system was in the range of 540nm-700nm. The sensor REDS has a high efficiency in identifying pH: in the presence of the above-mentioned various interfering substances, the fluorescence spectrum of the sensor REDS hardly changed at pH=4.0. When the pH value became 11.0, the fluorescence intensity of the sensor REDS at 578nm dropped sharply, and the fluorescence intensity at 614nm remained unchanged under the conditions of the presence of various other interfering substances. See the attached Figure 8 and attached Fig. 9 This result shows that the sensor REDS has a high fluorescence anti-interference recognition ability for pH.

[0064] Example 6: Stability of Compound 1 of the present invention as a fluorescence sensor for detecting pH

[0065] The stability of the sensor REDS was evaluated by measuring the fluorescence intensity at 578nm at different times under 522nm excitation. The fluorescence spectrum of the sensor REDS was tested every 5 minutes, and we found that the sensor REDS showed bright fluorescence at pH = 4.0, and the fluorescence intensity at 578nm remained basically unchanged after 60 minutes. In contrast, the sensor REDS had relatively low fluorescence intensity at pH 7.4 and 11.0, and the fluorescence intensity basically did not change within 60 minutes. All these experiments show that the sensor REDS has excellent stability in detecting pH. See attached Fig.10 .

[0066] Example 7: Stability of Compound 1 of the present invention as a fluorescence sensor for detecting pH

[0067] HCl and NaOH solutions were used to repeatedly adjust the pH value of the buffer solution to 4.0 or 11.0. After adjusting the solution pH back and forth between 4.0 and 11.0 8 times, the change in the fluorescence intensity of the sensor REDS at 578nm was observed. It was found that the fluorescence intensity at 578nm decreased as the pH increased from 4.0 to 11.0; when the pH decreased from 11.0 to 4.0, the fluorescence intensity returned to its original level. After 8 cycles, the sensor REDS still had the ability to detect alkaline pH, which shows that compound 1 has good reversibility. See attached Fig.11 .

[0068] Example 8: Study on the mechanism of the response of compound 1 of the present invention to pH as a fluorescence sensor

[0069] According to the protonation principle and published literature, the pH response mechanism of the sensor REDS is speculated. Compound 1 uses the hydroxyl group as the reaction site, and the hydroxyl group forms a hydrogen bond with the oxygen atom in the nitro group, which enhances the rigidity. At this time, the fluorescence intensity of the sensor is relatively large; under alkaline conditions, the hydrogen in the hydroxyl group is deprived, and the hydrogen bond between the hydroxyl group and the oxygen atom in the nitro group is destroyed, the TICT effect is enhanced, the fluorescence is weakened, and the UV-visible maximum absorption peak and fluorescence emission peak of the probe are both red-shifted. The specific principle is as follows:

[0070]

[0071] Example 9: Cytotoxicity evaluation of compound 1 of the present invention

[0072] In order to further explore the biological application of the sensor REDS, we used the probe to perform confocal fluorescence imaging in living cells. Before the biological imaging application, the cytotoxicity test was performed using the MTT method. The MTT assay showed that after incubating HepG2 cells with different concentrations of sensor REDS (0, 1, 5, 10, 20 μg / ml) for 12 hours, the 20 μg / ml sensor REDS still maintained a survival rate of more than 90% for the cytotoxicity of HepG2 cells. This shows that the sensor has good biocompatibility and safety and can be used for the next cell test. See attached Fig.12 .

[0073] Example 10: Confocal laser fluorescence microscopy imaging of pH changes of compound 1 of the present invention

[0074] We applied the sensor REDS to HepG2 living cells for laser confocal fluorescence microscopy imaging of alkaline pH changes. The specific steps are as follows: HepG2 cells were cultured in DMEM medium containing 10% calf serum at 37°C and a carbon dioxide concentration of 5%. First, the cells were planted in a confocal dish and incubated in an incubator for 12 hours. After the culture medium was washed with PBS buffer, 5 μM sensor REDS solution was added and incubated at 37°C for 4 hours. After incubating for 1 hour with PBS culture medium with pH = 7.5, 8, 8.5, and 9, the cells were washed twice with PBS buffer and placed under a confocal fluorescence microscope for imaging. We found that the fluorescence in the red channel gradually weakened as the pH changed from 7.5 to 9, indicating that the probe has good cell membrane permeability and can enter the cell through the cell membrane; and the sensor can perform cell imaging of pH changes in HepG2 cells. See Appendix Fig.13 .

[0075] The above is only a specific implementation of the present invention, which enables those skilled in the art to understand or implement the present invention. Although detailed descriptions are given with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions recorded in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments, and they should all be covered by the protection scope of the claims.

Claims

1. (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound, characterized in that The structural formula is as follows: 。 2. The method for preparing the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound according to claim 1, characterized in that: 4-(Diethylamino) salicylaldehyde, 3,5-dimethyl-4-nitroisoxazole and piperidine are dissolved in anhydrous ethanol and refluxed. After the solvent is removed by evaporation under reduced pressure, the solid is dissolved in dichloromethane and purified by column chromatography to obtain a pink solid, which is the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazole-5-yl)vinyl)phenol compound.

3. The method for preparing the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound according to claim 2, characterized in that: The molar ratio of the 4-(diethylamino) salicylaldehyde to 3,5-dimethyl-4-nitroisoxazole is 2:

1.

4. The method for preparing the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound according to claim 2, characterized in that: The molar ratio of 4-(diethylamino) salicylaldehyde, 3,5-dimethyl-4-nitroisoxazole and piperidine is 7:3.5:

3.

5. The method for preparing the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound according to claim 2, characterized in that: The reflux time is 72 h.

6. The method for preparing the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound according to claim 2, characterized in that: The column chromatography purification system is petroleum ether and ethyl acetate in a volume ratio of 6:

1.

7. Use of the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound of claim 1 in detecting pH for purposes other than disease diagnosis and treatment.

8. The use according to claim 7, characterized in that The compounds detect pH via UV-visible absorption spectroscopy or fluorescence intensity changes.

9. Use of the (E)-5-diethylamino-2-(2-(3-methyl-4-nitroisoxazol-5-yl)vinyl)phenol compound of claim 1 in the preparation of a pH sensor, wherein the pH sensor is used for bioanalysis, cell imaging, organelle targeting, and drug delivery and release.

Citation Information

Patent Citations

  • Use of nitrogen-containing heterocyclic radical substituted alkene compounds

    CN107118586A

  • 1-amino-3-phenoxy propane derivatives as modulator agents and their applications

    US5622953A